Two drugs being made available through the NHS subscription model
https://www.bbc.co.uk/news/health-61068074
"Drugs' watchdog NICE says cefiderocol and ceftazidime with avibactam offer value for money and will save lives.
These 'last line of defence' drugs will tackle severe infections which cannot be cleared by other treatments.
Under the deal, a fixed annual fee will be paid to manufacturers to cover their development costs, rather than individual payments for each dose."
Two drugs being made available through the NHS subscription model
https://www.bbc.co.uk/news/health-61068074
"Drugs' watchdog NICE says cefiderocol and ceftazidime with avibactam offer value for money and will save lives.
These 'last line of defence' drugs will tackle severe infections which cannot be cleared by other treatments.
Under the deal, a fixed annual fee will be paid to manufacturers to cover their development costs, rather than individual payments for each dose."